Actionnariat et activité des initiés pour Oramed Pharmaceuticals Inc. (ORMP): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $4.62 |
| Capitalisation | $189M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-02 | Hexter Joshua | M-Exempt | 50,000 | $184K |
| 2026-07-01 | Hexter Joshua | S-Sale | 137,000 | $611K |
| 2026-07-02 | Hexter Joshua | M-Exempt | 50,000 | $184K |
| 2026-07-01 | Gabay Avraham | S-Sale | 73,360 | $331K |
| 2026-03-30 | KIDRON NADAV | F-InKind | 44,818 | $148K |
| 2026-03-30 | Kidron Miriam | F-InKind | 435,084 | $1.4M |
| 2026-03-17 | Kidron Miriam | A-Award | 119,558 | |
| 2026-03-17 | KIDRON NADAV | A-Award | 167,005 | |
| 2026-03-17 | Hexter Joshua | A-Award | 95,889 | |
| 2026-03-17 | Gabay Avraham | A-Award | 95,889 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $3.9M | $4.0M | $5.0M | $3.3M | $19.3M | $77.2M | $40.5M | $9.1M | $54.4M | $45.9M |
| Placements à Court Terme | $27.1M | $16.2M | $25.5M | $29.0M | $20.6M | $16.9M | $115.3M | $153.0M | $87.5M | $79.9M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.6M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $31.2M | $20.3M | $31.0M | $33.3M | $40.5M | $95.3M | $157.1M | $162.6M | $143.2M | $133.3M |
| Immobilisations Corporelles | $16000 | $18000 | $17000 | $24000 | $176000 | $932000 | $1.8M | $1.6M | $1.1M | $1.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $42.8M | $38.7M | $47.4M | $34.7M | $44.6M | $128.0M | $161.6M | $220.6M | $155.3M | $230.9M |
| Dettes Fournisseurs | $1.4M | $571000 | $1.1M | $1.3M | $594000 | $2.6M | $2.2M | $551000 | $789000 | $443000 |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $51.0M | 0 | $285000 |
| Passifs Courants | $3.6M | $5.2M | $4.6M | $5.3M | $4.5M | $6.7M | $5.7M | $53.2M | $5.7M | $19.1M |
| Dette à Long Terme | $14000 | $18000 | -$7.8M | -$5.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $16.6M | $19.5M | $16.3M | $15.3M | $11.8M | $11.5M | $10.5M | $57.7M | $9.9M | $31.1M |
| Réserves | -$46.0M | -$56.5M | -$69.2M | -$81.1M | -$92.6M | -$114.9M | -$163.1M | -$157.6M | -$176.6M | -$123.4M |
| Capitaux Propres | $26.2M | $19.2M | $31.1M | $19.4M | $32.9M | $115.8M | $151.8M | $163.8M | $146.3M | $199.7M |
| Dette Totale | 0 | 0 | 0 | 0 | $75000 | $533000 | $894000 | $51.6M | $372000 | $825000 |
| Dette Nette | -$31.0M | -$20.1M | -$30.5M | -$32.3M | -$39.8M | -$93.6M | -$154.8M | -$110.4M | -$141.6M | -$125.1M |
| Fonds de Roulement | $27.6M | $15.1M | $26.5M | $28.0M | $36.0M | $88.7M | $151.4M | $109.4M | $137.5M | $114.2M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 4.98 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 1.91 |
Rentabilité
| Rentabilité des capitaux propres | 72.96% |
| Rentabilité du capital investi | -3.21% |
| Rentabilité des actifs | 47.31% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: CLNN · CNTB · CNTX · COYA · IFRX · IMA · KLRS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ORMP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions